Literature DB >> 34022464

Unsupervised home-based resistance training for community-dwelling older adults: A systematic review and meta-analysis of randomized controlled trials.

Asier Mañas1, Paola Gómez-Redondo2, Pedro L Valenzuela3, Javier S Morales4, Alejandro Lucía5, Ignacio Ara2.   

Abstract

BACKGROUND: We aimed to summarize evidence on the safety, adherence and effectiveness of home-based resistance training (UHBRT) for improving health-related endpoints in community-dwelling older adults.
METHODS: Randomized controlled trials of UHBRT in older adults (≥60yrs) were included after a systematic search (PubMed, CINAHL, PsycInfo, SPORTDiscus, Web of Science, MEDLINE, Cochrane Central Register of Controlled Trials) until 02/19/2021. Adverse events and adherence rates were assessed as indicators of feasibility. Other endpoints included physical (muscle strength, muscle power, balance, physical performance) and mental-related measures (cognition, quality of life [QoL]) as well as other health-related variables (body composition, physical activity levels, falls).
RESULTS: 21 studies (N = 4,053) were included. No major adverse events were reported, with adherence averaging 67 % (range 47-97 %). UHBRT significantly improved lower-limb muscle strength (Hedges' g = 0.33; 95 % confidence interval [CI] = 0.11-0.57), muscle power measured through the sit-to-stand test (g = 0.44; 95 %CI = 0.06-0.84), and balance (assessed with the postural sway, g = 0.32; 95 %CI = 0.16-0.49). No benefits were found for other strength indices (handgrip strength), balance (single leg stance and functional reach test), physical performance (walking speed, TUG and SPPB), QoL, nor for the risk or rate of falls (all p > 0.05, g<0.61). No meta-analysis could be performed for the remaining endpoints.
CONCLUSIONS: Although efforts are needed to increase adherence, preliminary evidence suggests that UHBRT can be safe and modestly effective for improving some measures of lower-limb muscle strength, balance, and muscle power in community-dwelling older adults. However, no benefits were found for other physical fitness measures, QoL or falls. More evidence is therefore needed to draw definite conclusions.
Copyright © 2021 Elsevier B.V. All rights reserved.

Keywords:  Cognition; Elderly; Exercise; Performance; Safety; Strength

Year:  2021        PMID: 34022464     DOI: 10.1016/j.arr.2021.101368

Source DB:  PubMed          Journal:  Ageing Res Rev        ISSN: 1568-1637            Impact factor:   10.895


  5 in total

Review 1.  Home-Based Physical Activity as a Healthy Aging Booster before and during COVID-19 Outbreak.

Authors:  Marianna De Maio; Cecilia Bratta; Alice Iannaccone; Loriana Castellani; Carl Foster; Cristina Cortis; Andrea Fusco
Journal:  Int J Environ Res Public Health       Date:  2022-04-04       Impact factor: 3.390

Review 2.  Strength training in elderly: An useful tool against sarcopenia.

Authors:  Roberto Cannataro; Erika Cione; Diego A Bonilla; Giuseppe Cerullo; Fabrizio Angelini; Giuseppe D'Antona
Journal:  Front Sports Act Living       Date:  2022-07-18

Review 3.  Effect of home-based exercise on falls in community-dwelling older adults: an umbrella review.

Authors:  Mohsen Shafizadeh; Shahab Parvinpour; Khalid Ali
Journal:  Sport Sci Health       Date:  2022-08-09

4.  Effects of Multicomponent Training Followed by a Detraining Period on Frailty Level and Functional Capacity of Older Adults with or at Risk of Frailty: Results of 10-Month Quasi-Experimental Study.

Authors:  Ángel Iván Fernández-García; Ana Moradell; David Navarrete-Villanueva; Jorge Subías-Perié; Jorge Pérez-Gómez; Ignacio Ara; Marcela González-Gross; José Antonio Casajús; Germán Vicente-Rodríguez; Alba Gómez-Cabello
Journal:  Int J Environ Res Public Health       Date:  2022-09-29       Impact factor: 4.614

Review 5.  A Review on Aging, Sarcopenia, Falls, and Resistance Training in Community-Dwelling Older Adults.

Authors:  Filipe Rodrigues; Christophe Domingos; Diogo Monteiro; Pedro Morouço
Journal:  Int J Environ Res Public Health       Date:  2022-01-13       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.